US Stock MarketDetailed Quotes

EYESW Second Sight Medical Products Inc C/Wts 14/03/2024(To Pur Com) R/S

Watchlist
  • 0.0000
  • 0.00000.00%
Close Nov 29 09:30 ET
0Market Cap0.00P/E (TTM)

Second Sight Medical Products Inc C/Wts 14/03/2024(To Pur Com) R/S Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
(Q3)Sep 30, 2020
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
0
0
74.00%-130K
74.00%-130K
0
0
0
-123.23%-500K
-503.23%-500K
0
Gross profit
0
0
-74.00%130K
-74.00%130K
0
0
0
-59.25%500K
34.05%500K
0
Operating expense
36.28%3.13M
-22.05%2.22M
-31.17%9.06M
-19.90%1.42M
56.24%2.5M
1.23%2.3M
-62.21%2.84M
-58.63%13.17M
-78.98%1.77M
-79.27%1.6M
Selling and administrative expenses
58.82%2.13M
-40.70%1.47M
-4.95%6.32M
-27.46%975K
44.07%1.53M
-11.74%1.34M
-9.18%2.47M
-56.65%6.64M
-59.81%1.34M
-69.54%1.06M
-Selling and marketing expense
----
----
--0
--0
--0
----
----
-88.51%701K
--0
--0
-General and administrative expense
58.82%2.13M
-40.70%1.47M
6.26%6.32M
-27.46%975K
44.07%1.53M
-11.74%1.34M
22.32%2.47M
-35.58%5.94M
-42.64%1.34M
-51.24%1.06M
Research and development costs
21.29%843K
93.11%645K
-50.99%2.37M
85.59%644K
149.82%697K
115.17%695K
-91.41%334K
-63.20%4.84M
-91.63%347K
-91.74%279K
Other operating expenses
-38.78%161K
183.78%105K
-77.59%378K
-338.55%-198K
5.75%276K
-38.69%263K
-95.95%37K
-49.70%1.69M
-91.26%83K
-69.72%261K
Operating profit
-36.28%-3.13M
22.05%-2.22M
29.48%-8.93M
-1.33%-1.29M
-56.24%-2.5M
-1.23%-2.3M
62.21%-2.84M
58.60%-12.67M
84.21%-1.27M
78.97%-1.6M
Net non-operating interest income expense
4K
-25.00%12K
0
-95.58%16K
Non-operating interest income
----
--4K
-25.00%12K
----
----
----
--0
-95.58%16K
----
----
Other net income (expense)
2,550.00%53K
300.00%2K
100.24%2K
33.60%-2.23M
79.88%-33K
-102.86%-1K
Special income (charges)
----
----
--0
--0
--0
----
----
33.60%-2.23M
--0
--0
-Less:Restructuring and merger&acquisition
----
----
--0
--0
--0
----
----
-33.60%2.23M
--0
--0
Other non- operating income (expenses)
2,550.00%53K
----
----
----
300.00%2K
--2K
----
----
----
-102.86%-1K
Income before tax
-34.09%-3.08M
22.19%-2.21M
40.05%-8.92M
0.62%-1.28M
-56.02%-2.5M
26.00%-2.29M
68.01%-2.84M
55.70%-14.88M
83.59%-1.29M
78.86%-1.6M
Income tax
Net income
-34.09%-3.08M
22.19%-2.21M
40.05%-8.92M
0.62%-1.28M
-56.02%-2.5M
26.00%-2.29M
68.01%-2.84M
55.70%-14.88M
83.59%-1.29M
78.86%-1.6M
Net income continuous Operations
-34.09%-3.08M
22.19%-2.21M
40.05%-8.92M
0.62%-1.28M
-56.02%-2.5M
26.00%-2.29M
68.01%-2.84M
55.70%-14.88M
83.59%-1.29M
78.86%-1.6M
Minority interest income
Net income attributable to the parent company
-34.09%-3.08M
22.19%-2.21M
40.05%-8.92M
0.62%-1.28M
-56.02%-2.5M
26.00%-2.29M
68.01%-2.84M
55.70%-14.88M
83.59%-1.29M
78.86%-1.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-34.09%-3.08M
22.19%-2.21M
40.05%-8.92M
0.62%-1.28M
-56.02%-2.5M
26.00%-2.29M
68.01%-2.84M
55.70%-14.88M
83.59%-1.29M
78.86%-1.6M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020(Q3)Sep 30, 2020
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue 0074.00%-130K74.00%-130K000-123.23%-500K-503.23%-500K0
Gross profit 00-74.00%130K-74.00%130K000-59.25%500K34.05%500K0
Operating expense 36.28%3.13M-22.05%2.22M-31.17%9.06M-19.90%1.42M56.24%2.5M1.23%2.3M-62.21%2.84M-58.63%13.17M-78.98%1.77M-79.27%1.6M
Selling and administrative expenses 58.82%2.13M-40.70%1.47M-4.95%6.32M-27.46%975K44.07%1.53M-11.74%1.34M-9.18%2.47M-56.65%6.64M-59.81%1.34M-69.54%1.06M
-Selling and marketing expense ----------0--0--0---------88.51%701K--0--0
-General and administrative expense 58.82%2.13M-40.70%1.47M6.26%6.32M-27.46%975K44.07%1.53M-11.74%1.34M22.32%2.47M-35.58%5.94M-42.64%1.34M-51.24%1.06M
Research and development costs 21.29%843K93.11%645K-50.99%2.37M85.59%644K149.82%697K115.17%695K-91.41%334K-63.20%4.84M-91.63%347K-91.74%279K
Other operating expenses -38.78%161K183.78%105K-77.59%378K-338.55%-198K5.75%276K-38.69%263K-95.95%37K-49.70%1.69M-91.26%83K-69.72%261K
Operating profit -36.28%-3.13M22.05%-2.22M29.48%-8.93M-1.33%-1.29M-56.24%-2.5M-1.23%-2.3M62.21%-2.84M58.60%-12.67M84.21%-1.27M78.97%-1.6M
Net non-operating interest income expense 4K-25.00%12K0-95.58%16K
Non-operating interest income ------4K-25.00%12K--------------0-95.58%16K--------
Other net income (expense) 2,550.00%53K300.00%2K100.24%2K33.60%-2.23M79.88%-33K-102.86%-1K
Special income (charges) ----------0--0--0--------33.60%-2.23M--0--0
-Less:Restructuring and merger&acquisition ----------0--0--0---------33.60%2.23M--0--0
Other non- operating income (expenses) 2,550.00%53K------------300.00%2K--2K-------------102.86%-1K
Income before tax -34.09%-3.08M22.19%-2.21M40.05%-8.92M0.62%-1.28M-56.02%-2.5M26.00%-2.29M68.01%-2.84M55.70%-14.88M83.59%-1.29M78.86%-1.6M
Income tax
Net income -34.09%-3.08M22.19%-2.21M40.05%-8.92M0.62%-1.28M-56.02%-2.5M26.00%-2.29M68.01%-2.84M55.70%-14.88M83.59%-1.29M78.86%-1.6M
Net income continuous Operations -34.09%-3.08M22.19%-2.21M40.05%-8.92M0.62%-1.28M-56.02%-2.5M26.00%-2.29M68.01%-2.84M55.70%-14.88M83.59%-1.29M78.86%-1.6M
Minority interest income
Net income attributable to the parent company -34.09%-3.08M22.19%-2.21M40.05%-8.92M0.62%-1.28M-56.02%-2.5M26.00%-2.29M68.01%-2.84M55.70%-14.88M83.59%-1.29M78.86%-1.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -34.09%-3.08M22.19%-2.21M40.05%-8.92M0.62%-1.28M-56.02%-2.5M26.00%-2.29M68.01%-2.84M55.70%-14.88M83.59%-1.29M78.86%-1.6M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data